Skip to content

A Randomized Clinical Trial of Fecal Microbiota Transplant for Treatment-Resistant Schizophrenia

A Randomized Clinical Trial of Fecal Microbiota Transplant for Treatment-Resistant Schizophrenia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045243
Enrollment
Unknown
Registered
2021-04-09
Start date
2021-03-30
Completion date
Unknown
Last updated
2021-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Sponsors

The Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of schizophrenia in DSM-5; 2. Patients who have not received clinical improvement after 4-6 weeks of adequate treatment with at least two antipsychotics in the past 5 years; 3. Aged 18-55 years, right-handed; 4. Primary school education and above; 5. All of them obtained the informed consent of the patient or the guardian and agreed to participate in this study.

Exclusion criteria

Exclusion criteria: 1. A history of major head trauma (loss of consciousness, time > 5min), CT or MRI suggest brain structural abnormalities, thyroid-related diseases, infectious diseases (hepatitis B, large and small Sanyang are excluded), nervous system diseases; 2. Previous history of other mental illness and history of drug or drug abuse; 3. Patients with severe somatic diseases such as heart, liver and renal insufficiency and poor control of diabetes and hypertension; 4. No antibiotics or probiotics have been used for nearly 2 months; 5. Complicated with other mental illness or alcohol or drug dependence, or whose diagnosis is unknown; 6. Pregnant or lactating women; 7. Unable to cooperate with those who complete the inclusion criteria and follow-up assessments.

Design outcomes

Primary

MeasureTime frame
Behavioral index;Intestinal microbiota;

Secondary

MeasureTime frame
Metabonomics;

Countries

China

Contacts

Public ContactXiang Bo

The Affiliated Hospital of Southwest Medical University

xbyl2012@126.com+86 17713762681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026